?
Blanchard Cheryl R
President, CEO, Director
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK
1326530
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
113,791
Price per Share :
$16.19
Equivalence :
$1,842,276.29
Transaction History
-
M113,791 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/10/23
-
Footnotes
-
-
Footnotes:#1 Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022.#2 Reflects an aggregate of 13,211 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023.#3 Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations.
-
F100,580 Shares After TransactionValue : $2,625,138.00$344,807.10Transaction Date : 03/10/23
-
Footnotes
-
-
Footnotes:#1 Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022.#2 Reflects an aggregate of 13,211 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023.#3 Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations.
-
M129,614 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.#2 Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023.#3 Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.#4 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.#5 Reflects the first vesting installment of RSUs granted on March 9, 2023.#6 Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
-
F122,641 Shares After TransactionValue : $3,117,534.22$177,253.66Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.#2 Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023.#3 Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.#4 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.#5 Reflects the first vesting installment of RSUs granted on March 9, 2023.#6 Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
-
M142,642 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.#2 Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023.#3 Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.#4 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.#5 Reflects the first vesting installment of RSUs granted on March 9, 2023.#6 Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.